0910-AF26 201210 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Blood Initiative--Revisions To Labeling Requirements for Blood and Blood Components, Including Source Plasma The Food and Drug Administration (FDA) is amending the regulations regarding container labels and instruction circulars for certain human blood and blood components, including source plasma, to be more consistent with current practices and to remove unnecessary or outdated requirements. This action is intended to help ensure the continued safety of the blood supply and to help ensure consistency in container labeling. The rule will also consolidate most of the regulations applicable to labeling standards for blood and blood components, including source plasma. Other Significant Previously Published in The Unified Agenda Completed Actions No No 21 CFR 606 21 CFR 610 21 CFR 640 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360 21 USC 360d 21 USC 360h to 360j 21 USC 371 21 USC 374 21 USC 381 42 USC 216 42 USC 262 and 263 42 USC 263a 42 USC 264 No NPRM 07/30/2003 68 FR 44678 NPRM Comment Period End 10/28/2003 Final Action 01/03/2012 77 FR 7 No No None No No 0910-AB26 Split from Benjamin Chacko 0910 Food and Drug Administration FDA 301 827-6210 Center for Biologics Evaluation and Research, Suite 200N (HFM-17), 1401 Rockville Pike, Rockville MD 20852